JOURNAL OF PSYCHOACTIVE DRUGS
Scope & Guideline
Pioneering Research in Psychoactive Substance Dynamics
Introduction
Aims and Scopes
- Psychedelic Research and Therapeutics:
The journal emphasizes the therapeutic potential of psychedelics, exploring their use in treating mental health disorders, substance use disorders, and other psychological conditions. - Substance Use Epidemiology:
Research focusing on the prevalence, patterns, and correlates of psychoactive substance use across different populations, including marginalized and vulnerable groups. - Cultural and Social Contexts of Drug Use:
Investigates the cultural, social, and community aspects of drug use, including stigma, identity, and the impact of drug policies on different populations. - Harm Reduction Strategies:
Promotes research on harm reduction approaches, assessing their effectiveness and implementation in various settings, particularly for high-risk substance users. - Psychosocial Factors and Substance Use:
Examines the psychological, social, and behavioral factors that influence substance use, including coping strategies, mental health comorbidities, and recovery processes.
Trending and Emerging
- Psychedelic-Assisted Therapies:
There is a growing body of research investigating the applications of psychedelics in therapeutic settings, especially concerning mental health disorders such as depression, PTSD, and anxiety. - Impact of Legalization and Policy Change:
Emerging studies focus on the implications of drug legalization and policy changes, particularly surrounding cannabis and the societal impacts of these shifts. - Intersection of Substance Use and Mental Health:
Research increasingly explores the interplay between substance use and mental health, highlighting comorbidities and integrated treatment approaches. - Community-Based Drug Interventions:
There is an increasing emphasis on community-level interventions and harm reduction strategies that consider local cultural contexts and community health. - Microdosing Practices and Effects:
The phenomenon of psychedelic microdosing is gaining traction, with studies examining its effects on creativity, mental health, and overall well-being.
Declining or Waning
- Traditional Drug Use Studies:
There is a noticeable decrease in studies focused solely on traditional or historical uses of substances without a contemporary context, reflecting a shift towards more applied and intervention-focused research. - Basic Pharmacological Studies:
Research centered on basic pharmacology of psychoactive substances, such as isolated pharmacodynamics or pharmacokinetics, has waned in favor of studies that address clinical implications and real-world applications. - General Attitudes Towards Drug Use:
Papers exploring general public attitudes towards drug use, without a specific focus on therapeutic or harm reduction implications, seem to be less frequently published. - Non-Psychoactive Substances:
Research on substances that are not considered psychoactive (e.g., certain dietary supplements or non-drug interventions) has become less common, as the journal's focus has shifted more towards psychoactive drugs.
Similar Journals
Journal of Addictions Nursing
Exploring New Frontiers in Mental Health and AddictionThe Journal of Addictions Nursing, published by Lippincott Williams & Wilkins, serves as a pivotal resource in the field of psychiatric and mental health nursing. With an ISSN of 1088-4602 and an E-ISSN of 1548-7148, this esteemed journal has been dedicated to advancing the knowledge and practice of addiction nursing since its inception in 1989. As of 2023, it ranks in the Q3 category of psychiatry and mental health, highlighting its significance amidst its peers. The journal provides a platform for the dissemination of original research, reviews, and clinical practices that address the complexities of addiction treatment and care. While it currently does not offer open access options, its valuable insights are accessible to practitioners and researchers committed to improving patient outcomes. With content spanning from 1989 to 2024, the journal continues to shape the discourse in this vital area of nursing, making it an essential read for professionals and scholars aiming to stay at the forefront of addiction nursing and intervention strategies.
Suchttherapie
Advancing the Dialogue on Addiction TreatmentSuchttherapie, an esteemed journal published by GEORG THIEME VERLAG KG, serves as a critical platform within the fields of Applied Psychology and Psychiatry and Mental Health. Established in 2000 and continuing through 2024, this journal is committed to advancing the understanding and treatment of addiction and related psychological issues. Although it currently stands in the Q4 Quartile ranking and is categorized as low percentile in both Scopus Ranks and impact metrics, its significance lies in its dedication to disseminating cutting-edge research and clinical findings that contribute to the evolving landscape of therapeutic practices. Published in Germany, the journal facilitates unlimited access to the vital discourse surrounding mental health and addiction treatment, making it a valuable resource for researchers, professionals, and students alike seeking to enhance their knowledge and skills in this important area of study. As the field continues to grow, Suchttherapie plays a pivotal role in bridging practice with academic rigor, ensuring that readers remain informed on the latest methodologies and insights.
DRUGS-EDUCATION PREVENTION AND POLICY
Cultivating informed discussions on drug prevention and policy.DRUGS-EDUCATION PREVENTION AND POLICY is a premier scholarly journal published by Taylor & Francis Ltd, focusing on the critical intersection of drug education, prevention strategies, and policy formulation. Established in 1994 and continuing through its converged years into 2024, this journal holds significant relevance within the health and social sciences fields, with commendable standings reflected in its 2023 category quartile rankings of Q2 in both Health (Social Science) and Medicine (Miscellaneous). With an impact ranking that places it in the 73rd and 67th percentiles respectively, it serves as an influential platform for researchers, professionals, and students to disseminate innovative research, case studies, and policy analyses. Those interested in the complexities of drug-related issues are encouraged to explore the insights provided by this journal, contributing to the ongoing discourse in effective prevention and education practices in the context of drug use and its social implications. Although access to articles is not open, the wealth of knowledge presented is invaluable for academia and policy formulation alike.
Journal of Substance Use & Addiction Treatment
Advancing knowledge, transforming lives.Journal of Substance Use & Addiction Treatment is a premier scholarly publication dedicated to advancing the understanding and treatment of substance use disorders and addictive behaviors. Published by Elsevier Science Inc, this journal serves as a vital platform for researchers, clinicians, and students in the fields of psychology, psychiatry, public health, and addiction studies. With its commitment to Open Access, the journal facilitates wide dissemination of cutting-edge research, enabling practitioners and policymakers to access critical findings that inform treatment approaches and public health strategies. As an essential resource in addiction treatment and research, the Journal of Substance Use & Addiction Treatment aims to foster interdisciplinary collaboration and innovation, ultimately improving outcomes for individuals affected by addiction.
AMERICAN JOURNAL ON ADDICTIONS
Exploring New Frontiers in Addiction MedicineThe AMERICAN JOURNAL ON ADDICTIONS, published by WILEY, stands as a premier publication within the realms of Clinical Psychology, Medicine, and Psychiatry. With its ISSN 1055-0496 and E-ISSN 1521-0391, the journal has been a critical resource since its inception in 1992, consistently evolving to encompass a wide scope of addiction research and its implications on public health. Renowned for its rigorous peer-reviewed articles, it boasts impressive rankings, including Q1 status in both Clinical Psychology and Medicine (miscellaneous) for 2023, and a respectable Q2 in Psychiatry and Mental Health. As a foundational platform for disseminating cutting-edge research, the journal aims to facilitate the exchange of knowledge among researchers, healthcare professionals, and educators alike. Its significant impact on the academic community is underscored by its Scopus rankings—placing it in the top 26% of Clinical Psychology journals and the top 28% in Medicine (miscellaneous). By fostering an understanding of addiction and its treatments, the AMERICAN JOURNAL ON ADDICTIONS plays an essential role in guiding innovative practices and shaping future policies within the field.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
Empowering Scholars with Insights into Addiction DynamicsAmerican Journal of Drug and Alcohol Abuse is a highly regarded publication in the field of substance abuse research, published by Taylor & Francis Inc. With its inception in 1974, this journal has become an essential resource for scholars and practitioners interested in clinical psychology, psychiatry, and the multifaceted issues surrounding drug and alcohol use. It holds a notable Q2 ranking in Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health, emphasizing its impact and relevance in these domains. The journal's 2023 Scopus rankings further highlight its standing, placing it in the top quartile of publications with established readership and citation metrics. Researchers and students can benefit from its comprehensive articles that delve into the complexities of substance use, treatment methodologies, and the socio-psychological underpinnings of addiction. Whether you seek to access cutting-edge studies or contribute to ongoing discourse in the field, the American Journal of Drug and Alcohol Abuse serves as a vital hub for knowledge dissemination and scholarly engagement.
Journal of Dual Diagnosis
Integrating care for a healthier tomorrow.The Journal of Dual Diagnosis, published by Routledge Journals, Taylor & Francis Ltd, is a leading interdisciplinary platform dedicated to the critical study of co-occurring mental health and substance use disorders. With its ISSN 1550-4263 and E-ISSN 1550-4271, this esteemed journal has been at the forefront of advancing research and clinical practice since its inception in 2004, and continues to serve as a vital resource until 2024. Ranked in the second quartile (Q2) in Psychiatry and Mental Health and positioned at the 64th percentile in the Scopus rankings, it emphasizes the importance of integrating care across various domains of health. Although not open access, it offers a wealth of peer-reviewed articles, case studies, and reviews suitable for researchers, practitioners, and students alike, aiming to enhance our understanding and treatment of dual diagnosis. The journal's commitment to addressing the complexities of dual disorders not only informs research but also shapes policy and clinical guidelines, making it an essential read for anyone involved in these critical areas of mental health.
Nordic Studies on Alcohol and Drugs
Bridging Research and Policy in Nordic Alcohol and Drug StudiesNordic Studies on Alcohol and Drugs is a leading peer-reviewed journal published by SAGE PUBLICATIONS LTD, dedicated to advancing the understanding of alcohol and drug use from a Nordic perspective. Established in 1989 and operating as an Open Access journal since 2011, it provides a platform for researchers and professionals in the fields of health policy and social sciences, focusing on empirical research and interdisciplinary studies. With a commendable 2023 Impact Factor, ranking Q2 in both Health Policy and Health (Social Science), it has carved a significant niche in the scholarly community, fostering discussions around public health and drug-related issues. The journal covers diverse topics relevant to the Nordic context, making it a valuable resource for those seeking to understand patterns of alcohol and drug consumption and their implications. The journal reaches an international audience, underscoring its relevance across national borders, and aims to facilitate collaboration and knowledge sharing among scholars, practitioners, and policymakers.
Drugs Habits and Social Policy
Advancing Insights for Health Policy TransformationDrugs Habits and Social Policy is an esteemed academic journal published by Emerald Group Publishing Ltd that focuses on the intersection of drug habits and the evolving landscape of social policy. With an ISSN of 2752-6739 and E-ISSN of 2752-6747, this journal contributes significantly to the fields of Clinical Psychology, Health Policy, and Public Health, and is ranked in the Q3 category across multiple disciplines in the 2023 categorizations. Featuring research that spans from 2022 to 2024, the journal provides a platform for critical insights and evidence-based discussions that are essential for understanding the social implications of drug use. Despite its current quartile ranking, the journal aims to elevate discourse among researchers, professionals, and students alike, reinforcing its commitment to impactful scholarship that can inform policy and practice. The journal is based in the United Kingdom, with its operations housed at Floor 5, Northspring 21-23 Wellington Street, Leeds, W YORKSHIRE LS1 4DL, ENGLAND. As a pivotal resource in its field, Drugs Habits and Social Policy invites contributions that can shape the future of health policy and improve societal outcomes.
Journal of Studies on Alcohol and Drugs
Uncovering insights into health and substance use.The Journal of Studies on Alcohol and Drugs is a premier academic journal dedicated to advancing the understanding of alcohol and drug use, its effects, and its societal implications. Published by ALCOHOL RES DOCUMENTATION INC at the Center for Alcohol Studies, Rutgers University, this journal features comprehensive research that spans the disciplines of health, psychiatry, mental health, and toxicology. With its Q1 ranking in Health (Social Science) and Q2 ranking in Psychiatry and Mental Health, the journal plays a vital role in disseminating high-impact research that informs policy, prevention, and treatment strategies in addiction and substance use. The journal contributes significantly to the field, as evidenced by its solid Scopus rankings and engagement with contemporary issues, making it an essential resource for researchers, practitioners, and students. Although it does not offer open access, the journal's commitment to rigorous peer review and scholarship ensures that it remains at the forefront of research on alcohol and drugs through its converged publication timeline from 2007 to 2024.